Age, Biography and Wiki
Akshay Nair was born on 1984 in Mumbai, India, is an Indian ophthalmologist. Discover Akshay Nair's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 40 years old?
| Popular As |
N/A |
| Occupation |
Ophthalmologist |
| Age |
40 years old |
| Zodiac Sign |
N/A |
| Born |
1984 |
| Birthday |
|
| Birthplace |
Mumbai, India |
| Nationality |
Mumbai
|
We recommend you to check the complete list of Famous People born on .
He is a member of famous with the age 40 years old group.
Akshay Nair Height, Weight & Measurements
At 40 years old, Akshay Nair height not available right now. We will update Akshay Nair's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Akshay Nair Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Akshay Nair worth at the age of 40 years old? Akshay Nair’s income source is mostly from being a successful . He is from Mumbai. We have estimated Akshay Nair's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Akshay Nair Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Akshay Nair is an Indian ophthalmologist based in Mumbai, India.
He specializes in oculoplastics, orbital surgery and ocular oncology.
Currently, Dr. Nair is the Director of Ophthalmic plastic surgery and ocular oncology services at the Mumbai units of Dr. Agarwal's Eye Hospital: Advanced Eye Hospital and Institute and Aditya Jyot Eye Hospital.
Dr. Nair trained in ophthalmology at Sankara Nethralaya in Chennai, India.
He subsequently completed a fellowship in oculoplastics and ocular oncology at L. V. Prasad Eye Institute under Santosh Honavar among others.
He also completed a fellowship in orbital surgery supported by the International Council of Ophthalmology at the New York Eye and Ear Infirmary of Mount Sinai in New York, USA.
Specialising in eyelid, orbital and thyroid eye disease surgery, Dr. Nair was one of the first clinicians to report and study the association between the invasive fungal infection Mucormycosis, COVID-19 and recent-onset diabetes which was seen after the second wave of the COVID-19 pandemic in India.
Notably, in 2021 Nair and Dave proposed a novel protocol for case selection of patients suitable for orbital injection of the antifungal drug, Amphotericin-B which has helped improve outcomes in rhino-orbital mucormycosis, a disease traditionally known to have high mortality rates.
In this regard, he has been interviewed as an expert extensively by The Times, BBC News, Barkha Dutt, Qatar-based news channel Al Jazeera, the French daily Le Figaro and The Washington Post.
As of 2022, Dr. Akshay Nair has published over 120 scientific papers in peer-reviewed journals and features in the top 2% of the most-cited researchers globally in 2021 across all specialities (published by Elsevier).
Dr. Nair also serves as a consultant for HelpMeSee in developing in a surgical simulator.
He is an elected officer in the executive committees of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery and the Oculoplastics Association of India.
Additionally, Dr. Nair has been inducted as an editorial board member on the American Academy of Ophthalmology-ONE network Oculoplastics/Orbital Surgery sub-section; becoming the first international (non-American) member to be inducted for a term of 5 years.
